Visit Acquired By Cliantha Trust

Visit Health, a healthtech platform, recently announced the successful raise of over ₹250 crore through a combination of primary capital infusion and secondary purchase of shares held by Docprime Technologies, a wholly-owned subsidiary of PB Fintech, along with contributions from other promoters and employees.

This capital infusion is set to fuel the company’s ambitious growth strategy across three critical pillars: people, network, and technology.

“We are looking at using this fund for three main pillars of any company, which is people, network, and technology. So we would appreciate good, like-minded folks joining our team. And obviously, the network is going to play a very critical role in primary health care,” Vaibhav Singh, Co-Founder & MD of Visit Health stated in an interview with CNBC-TV18.

He emphasised the importance of expanding the network to include preferred doctors and clinics in Tier-II, III, and IV cities and enhancing technological capabilities to provide a seamless, cashless healthcare experience.

Visit Health’s commitment to bridging the gap in primary healthcare is further evident in its comprehensive service offerings. Singh highlighted that the platform covers all aspects of primary healthcare, which is essential for day-to-day health management before hospitalisation.

About Buyer

Cliantha Trust is the CSR arm of Cliantha Research, a full-service clinical research organization that originated as the clinical trials division of Zydus. The trust focuses on healthcare, education, and community development initiatives, continuing its legacy of improving public health outcomes.

About Seller

Visit Health is a digital health and wellness platform offering integrated healthcare solutions including telemedicine, mental wellness, diagnostics, and insurance support. It partners with employers to provide employees unified access to healthcare services through a single app.
www.getvisitapp.com